After a reperfused myocardial infarction (MI), dynamic tissue changes occur (edema,
inflammation, microvascular obstruction, hemorrhage, cardiomyocyte necrosis, and …

Although mortality after ST-segment elevation myocardial infarction (MI) is on the decline,
the number of patients develo** heart failure as a result of MI is on the rise. Apart from …

Objectives: The aim of this study was to assess whether deferred stenting might reduce no-
reflow and salvage myocardium in primary percutaneous coronary intervention (PCI) for ST …

Objectives: This study aimed to determine whether remote ischemic conditioning (RIC)
initiated prior to primary percutaneous coronary intervention (PPCI) could reduce myocardial …

Background—The success of coronary reperfusion therapy in ST-segment–elevation
myocardial infarction (MI) is commonly limited by failure to restore microvascular perfusion …

Background Current cardiovascular magnetic resonance (CMR) methods, such as late
gadolinium enhancement (LGE) and oedema imaging (T2W) used to depict myocardial …

Objectives: The aim of this study was to determine whether cardiac magnetic resonance
(CMR) in vivo T1 map** can measure myocardial area at risk (AAR) compared with …

Hypertrophic cardiomyopathy (HCM) is a genetic heart disease characterized by the
thickening of the heart muscle, which can lead to symptoms such as chest pain, shortness of …

Background: Primary percutaneous coronary intervention is frequently successful at
restoring coronary artery blood flow in patients with acute ST-segment–elevation myocardial …

Background: It is widely accepted that edema occurs early in the ischemic zone and persists
in stable form for at least 1 week after myocardial ischemia/reperfusion. However, there are …